W146 hydrate

SIGMA/W1020 - ≥98% (HPLC)

Synonym: ML056; R-3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid hydrate; [(3R)-3-amino-4-[(3-hexylphenyl)amino]-4-oxobutyl]-phosphonic acid

CAS Number: 909725-61-7 (anhydrous)
Empirical Formula (Hill Notation): C₁₆H₂₇N₂O₄P · xH₂O
Molecular Weight: 342.37 (anhydrous basis)
MDL Number: MFCD16875441
Linear Formula: C₁₆H₂₇N₂O₄P · xH₂O
Product Type: Chemical

Catalog Number	PKG Qty.	Price


45-W1020-1MG	1 mg	$233.00 1/EA	Add To Favorites
45-W1020-5MG	5 mg	$923.00 1/EA	Add To Favorites

Properties
Descriptions
Safety Info.
Basic Data

assay	≥98% (HPLC)
color	off-white
form	powder
InChI	1S/C16H27N2O4P.H2O/c1-2-3-4-5-7-13-8-6-9-14(12-13)18-16(19)15(17)10-11-23(20,21)22;/h6,8-9,12,15H,2-5,7,10-11,17H2,1H3,(H,18,19)(H2,20,21,22);1H2/t15-;/m1./s1
InChI key	DQKSZHVSROOTFY-XFULWGLBSA-N
originator	Novartis
Quality Level	100
SMILES string	O.CCCCCCc1cccc(NC(=O)[C@H](N)CCP(O)(O)=O)c1
solubility	methanol: soluble (with 0.1% TFA)
storage temp.	2-8°C

Application:	W146 hydrate has been used to assess vascular permeability in mice.
Biochem/physiol Actions:	Potent S1P(1) competitive antagonist; Ki = 10-77 nM.
Features and Benefits:	This compound is featured on the Lysophospholipid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here .
Features and Benefits:	This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here .
General description:	W146 hydrate functions as an orthosteric antagonist. It is associated with blood lymphopenia and lung edema in mice.
Packaging:	1, 5 mg in glass bottle

RIDADR	NONH for all modes of transport
WGK Germany	WGK 3
Flash Point(F)	Not applicable
Flash Point(C)	Not applicable

Purity	≥98% (HPLC)
Storage Temp.	2-8°C
UNSPSC	12352211

To Order From a Quote